Literature DB >> 3654901

Factors associated with the risk of second primary breast cancer: an analysis of data from the Connecticut Tumor Registry.

P L Horn1, W D Thompson, S M Schwartz.   

Abstract

To examine further the epidemiology of contralateral primary breast cancer, a case-control analysis, utilizing information available from the Connecticut Tumor Registry, was conducted. Recent cases of second primary breast cancer were compared to control women who had survived a first breast cancer but had not developed a second. Three hundred and thirty eight incident cases of contralateral breast cancer diagnosed between 1979 and 1982 were identified and compared with an equal number of randomly selected controls and 336 controls frequency matched to the cases on the basis of age at initial cancer diagnosis and the calendar time elapsing since that diagnosis. Risk of second primary breast cancer was found to be significantly elevated among women whose initial cancer was lobular carcinoma and during the first year following diagnosis of the initial primary. Additionally, for women initially treated with radiotherapy, risk of a contralateral primary increased for 10-14 years following treatment, after which it declined. Among young women, having never married was protective whereas the opposite was found among older women. These findings and the methods used are discussed in the context of the epidemiology of both contralateral and initial breast primaries.

Entities:  

Mesh:

Year:  1987        PMID: 3654901     DOI: 10.1016/0021-9681(87)90114-7

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  13 in total

1.  Social relationships, recovery from illness, and survival: a literature review.

Authors:  A Reifman
Journal:  Ann Behav Med       Date:  1995

Review 2.  ATM, radiation, and the risk of second primary breast cancer.

Authors:  Jonine L Bernstein; Patrick Concannon
Journal:  Int J Radiat Biol       Date:  2017-07-27       Impact factor: 2.694

Review 3.  Second primary breast cancer.

Authors:  O Eremin
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

4.  Risk of contralateral breast cancer among women with carcinoma in situ of the breast.

Authors:  L A Habel; R E Moe; J R Daling; S Holte; M A Rossing; N S Weiss
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

5.  Second primary breast cancer occurrence according to hormone receptor status.

Authors:  Allison W Kurian; Laura A McClure; Esther M John; Pamela L Horn-Ross; James M Ford; Christina A Clarke
Journal:  J Natl Cancer Inst       Date:  2009-07-09       Impact factor: 13.506

6.  Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.

Authors:  Babette Siebold Saltzman; Kathleen E Malone; Jean A McDougall; Janet R Daling; Christopher I Li
Journal:  Breast Cancer Res Treat       Date:  2012-08-19       Impact factor: 4.872

7.  Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.

Authors:  Marilyn Stovall; Susan A Smith; Bryan M Langholz; John D Boice; Roy E Shore; Michael Andersson; Thomas A Buchholz; Marinela Capanu; Leslie Bernstein; Charles F Lynch; Kathleen E Malone; Hoda Anton-Culver; Robert W Haile; Barry S Rosenstein; Anne S Reiner; Duncan C Thomas; Jonine L Bernstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-14       Impact factor: 7.038

8.  A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

Authors:  L S Cook; E White; S M Schwartz; B McKnight; J R Daling; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

9.  Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy.

Authors:  Wei Zhang; Aldo Becciolini; Annibale Biggeri; Paolo Pacini; Colin R Muirhead
Journal:  Breast Cancer Res       Date:  2011-04-04       Impact factor: 6.466

10.  Relation of risk of contralateral breast cancer to the interval since the first primary tumour.

Authors:  C Rubino; R Arriagada; S Delaloge; M G Lê
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.